NasdaqGS:LFSTHealthcare
A Look At LifeStance Health Group (LFST) Valuation As New Outcomes Data Highlights Care Model Effectiveness
Clinical outcomes data as a potential input for investors
LifeStance Health Group (LFST) released new clinical outcomes data covering roughly 180,000 patients across 33 states, reporting clinically significant symptom improvements in anxiety and depression that may interest investors tracking quality of care metrics.
According to the company, 79% of patients treated for anxiety and 73% of those treated for depression showed clinically significant improvements based on GAD-7 and PHQ-9...

